Author

Daniel J. Mount

Department of Pathology, Northwestern University Feinberg School of Medicine - Cited by 76,947 - Glioma - neuropathology - genetics - hypoxia - tumor microenvironment

Biography

Working at The Pennsylvania State University, 227 Mateer Building, University Park, PA 16802, Place of living is  Tanzania. Subjects of Specialization are Interior design; Interpretive; Nature interpretation centre; Physical setting; Taman Wetland
Title
Cited by
Year
The 2021 WHO classification of tumors of the central nervous system: a summary
DN Louis, A Perry, P Wesseling, DJ Brat, IA Cree, D Figarella-Branger, ...Neuro-oncology 23 (8), 1231-1251, 2021202
3652
2021
Glioma progression is shaped by genetic evolution and microenvironment interactions
FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ...Cell 185 (12), 2184-2199. e16, 2022202
87
2022
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
VA Arrieta, AX Chen, JR Kane, SJ Kang, C Kassab, C Dmello, J Zhao, ...Nature cancer 2 (12), 1372-1386, 2021202
23
2021
Hypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repair
M DeBerge, C Lantz, S Dehn, DP Sullivan, AM van der Laan, ...Journal of Experimental Medicine 218 (9), e0667, 212
20
2021
Molecular biomarker testing for the diagnosis of diffuse gliomas: guideline from the College of American Pathologists in collaboration with the American Association of …
DJ Brat, K Aldape, JA Bridge, P Canoll, H Colman, MR Hameed, ...Archives of pathology & laboratory medicine 146 (5), 547-574, 2022202
19
2022
Necrotic reshaping of the glioma microenvironment drives disease progression
SM Markwell, JL Ross, CL Olson, DJ BratActa Neuropathologica 143 (3), 291-310, 2022202
18
2022
Molecular biomarker-defined brain tumors: epidemiology, validity, and completeness in the United States
JB Iorgulescu, C Sun, C Neff, G Cioffi, C Gutierrez, C Kruchko, J Ruhl, ...Neuro-oncology 24 (11), 1989-2000, 2022202
17
2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations …
D Pratt, Z Abdullaev, A Papanicolau-Sengos, C Ketchum, ...Acta neuropathologica 143 (3), 403-414, 2022202
10
2022
Radiation therapy for IDH-mutant grade 2 and grade 3 diffuse glioma: an ASTRO clinical practice guideline
LM Halasz, A Attia, L Bradfield, DJ Brat, JP Kirkpatrick, NN Laack, ...Practical radiation oncology 12 (5), 370-386, 2022202
9
2022
A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell‐of‐origin dependent effects of H3K27M
Y Tomita, Y Shimazu, A Somasundaram, Y Tanaka, N Takata, Y Ishi, ...Glia 70 (9), 161-169, 2022202
8
2022
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
S Dhar, S Gadd, P Patel, J Vaynshteyn, GP Raju, R Hashizume, DJ Brat, ...Acta neuropathologica communications 10 (1), 1-14, 2022202
7
2022
Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions
KA Waite, G Cioffi, C Kruchko, N Patil, DJ Brat, JM Bruner, RE McLendon, ...Neuro-Oncology Practice 9 (4), 31-32, 2022202
7
2022
Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastases
AE Kim, GM Wang, KA Waite, S Elder, A Fine, MS Ahluwalia, D Brat, ...Neuro-Oncology Practice 8 (6), 662-63, 2021202
7
2021
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
VA Arrieta, C Dmello, DJ McGrail, DJ Brat, C Lee-Chang, AB Heimberger, ...The Journal of Clinical Investigation 133 (2), 2023202
5
2023
National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States
QT Ostrom, ML Shoaf, G Cioffi, K Waite, C Kruchko, PY Wen, DJ Brat, ...Neuro-oncology 2 (4), 799-807, 2023202
5
2023
Validation of whole genome methylation profiling classifier for central nervous system tumors
L Santana-Santos, KL Kam, D Dittmann, S De Vito, M McCord, P Jamshidi, ...The Journal of Molecular Diagnostics 2 (8), 92-93, 2022202
4
2022
The 2021 WHO classification of central nervous system tumors: what neurologists need to know
P Jamshidi, DJ BratCurrent opinion in neurology 35 (6), 76-771, 2022202
4
2022
Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis
BA Alexiev, BS Finkelman, L Streich, MM Bautista, SM Pollack, ...Pathology-Research and Practice 22, 153531, 2021202
4
2021
TOP2B enzymatic activity on promoters and introns modulates multiple oncogenes in human gliomas
E Gonzalez-Buendia, J Zhao, L Wang, S Mukherjee, D Zhang, VA Arrieta, ...Clinical Cancer Research 27 (20), 5669-5680, 2021202
3
2021
Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
G Zhao, P Newbury, Y Ishi, E Chekalin, B Zeng, BS Glicksberg, A Wen, ...Acta Neuropathologica Communications 10 (1), 1-15, 0
2
2022

Referred From: https://scholar.google.com/citations?user=ljnzPcoAAAAJ&hl=en

Cited by
Citations 76947
h-index 113
i10-index 295
Recommended Journals
Open Access Journals